Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EDIT
EDIT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EDIT News
Investment Choices in Gene Editing Sector
May 31 2026
NASDAQ.COM
Investment Choices in Gene Editing Technology
May 31 2026
Fool
Investment Choices in Gene Editing Technology
May 31 2026
Yahoo Finance
Q32 Bio Soars Over 85% on $55 Million Private Placement Announcement
May 28 2026
NASDAQ.COM
Editas Medicine Prices Public Offering of 55.6 Million Shares
May 26 2026
NASDAQ.COM
Editas Medicine Prices Public Offering at $2.25 per Share
May 26 2026
Newsfilter
Editas Medicine Launches Public Offering, Shares Drop Nearly 12%
May 26 2026
seekingalpha
Editas Medicine Launches Underwritten Public Offering
May 26 2026
Newsfilter
Editas Medicine Unveils New Data on EDIT-401 for Hyperlipidemia
May 14 2026
Newsfilter
Editas Medicine Q1 Earnings Report Analysis
May 05 2026
seekingalpha
Editas Medicine Announces Multiple Conference Presentations
Apr 27 2026
Newsfilter
Editas Medicine Wins CRISPR Patent Dispute Favoring Broad Institute
Mar 27 2026
NASDAQ.COM
Editas Medicine Faces Ongoing Decline Risks
Mar 17 2026
Fool
Editas Medicine Q4 Earnings Beat Expectations
Mar 09 2026
seekingalpha
Three Genomics Stocks Worth Adding to Your Portfolio
Nov 18 2025
NASDAQ.COM
Janux Therapeutics, Inc. (JANX) Announces Q3 Loss but Exceeds Revenue Projections
Nov 07 2025
NASDAQ.COM
Show More News
